Michael Abrams - Aug 31, 2023 Form 4 Insider Report for Arch Therapeutics, Inc. (ARTH)

Role: CHIEF FINANCIAL OFFICER
Signature: /s/ Michael Abrams
Stock symbol: ARTH
Transactions as of: Aug 31, 2023
Transactions value $: $2,830
Form type: 4
Date filed: 9/8/2023, 05:47 PM
Previous filing: Nov 10, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ARTH	Common Stock	Purchase	$2.83K	+10.3K		$0.28^*	10.3K	Aug 31, 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ARTH	Warrants (right to buy)	Award		+20.6K			20.6K	Aug 31, 2023	Common Stock	20.6K	$1.00	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The warrants are exercisable after the earlier of (A) the six-month anniversary after the date of issuance and (B) the date that a registration statement registering the shares underlying the warrants is declared effective.
F2	The warrants were sold as part of a unit with the shares of common stock reported in Table I, at a price of $0.275 per share of common stock and accompanying warrant to purchase two shares of common stock.